To better understand the serological response to recurrent IIV vaccination with antigenically similar vaccine strains, the serological IgA antibody titers were quantified against the H1N1 HA vaccine component (A/California/07/09) in young and elderly subjects vaccinated over three consecutive northern hemisphere influenza seasons (2014 to 2016) (Figure 2A). This evidence concerns the gene CD79A and influenza.